Several vaccine maker stocks slipped in after-hours trading Monday after Health Secretary Robert F. Kennedy Jr. announced a ...

It scares me to think of what’s ahead,” said Michael Osterholm, director of the University of Minnesota’s Center for ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce ...

A man accused of yelling "Free Palestine" and throwing Molotov cocktails at demonstrators calling for the release of Israeli ...

Pharmac’s current proposal would fund only the Comirnaty vaccine, with alternative brands available solely through its Exceptional Circumstances framework. ACA believes this creates an exclusionary ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

With U.S. recommendations for COVID-19 vaccines in flux, a leading member of the CDC's COVID vaccine advisory group is ...

By Stephanie Brown HealthDay ReporterTUESDAY, June 3, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...

Unpredictable and politically driven regulatory approaches cultivate an environment of enormous uncertainty for vaccine ...

Moderna MRNA announced the FDA approval for mRNA-1283, its next-generation refrigerator-stable COVID-19 vaccine, though for a ...